Thulium Laser Vaporisation of Prostate (THUVAP) is a minimally invasive surgical procedure used to treat Benign Prostatic Hyperplasia (BPH), a common condition in older men where the prostate gland enlarges and causes urinary problems. THUVAP uses a laser to vaporize the excess prostate tissue, providing relief from urinary symptoms.
During the procedure, the surgeon inserts a small fiber-optic camera (endoscope) through the urethra and into the prostate. A laser is then used to vaporize the excess prostate tissue, without the need for enucleation (removal) of the prostate tissue. The vaporized tissue is then flushed out of the bladder through the urethra.
THUVAP has several advantages over traditional surgery for BPH. It is a minimally invasive procedure that requires only a small incision in the urethra, reducing the risk of bleeding and infection. Patients typically experience less pain and have a faster recovery time than with traditional surgery.
In addition, THUVAP has a lower risk of complications, such as incontinence and erectile dysfunction, compared to traditional surgery. It also allows for precise removal of the tissue, while minimizing damage to surrounding tissue and reducing the risk of complications.
THUVAP is a safe and effective treatment option for men with BPH. However, as with any surgical procedure, there are risks involved, and patients should discuss the potential risks and benefits with their doctor. THUVAP may not be suitable for all patients, and alternative treatments may be recommended based on individual circumstances.
Overall, Thulium Laser Vaporisation of Prostate (THUVAP) is a promising and effective treatment for BPH that offers patients a minimally invasive option with reduced risk of complications and faster recovery time. It may be particularly useful for patients with smaller prostates or those who are not candidates for other surgical procedures due to medical conditions or medications.